Replies to post #144336 on Cytodyn Inc (CYDY)

[kgromax]

CD10 / NEWS2 as every professional statistican knows are pure datamining.

That means: the company, Cytodyn, handpicked out of 20 statistics (and probably much more, they never disclosed exactly how deep they datamined and how many subsets of patients were analyzed) the most favorable one.

It's pretty obvious really for a statistician. It's called picking the best card out of a 52 cards set and marketing it as a "win". Anybody could do it. Give me 52 cards and I can show you an ace.

What is much harder: force me to pick a single card, BLINDED. That will be MUCH harder for me to obtain an ace.

CD10 was a failure. The proof is: despite the huge pandemic crisis, zero countriies have approved Leronlimab based on CD10 detailed data (that, today, HAS NOT BEEN DISCLOSED TO SHAREHOLDERS). It's pretty simple.